Michael Bo Pålsson

Upfront Chromatography A/S develops a customized protein separation process. The firm offers industrial-scale customized separation solutions to isolate and purify soluble proteins from industrial process streams. Its core protein purification technology, rhobust, is applicable to industrial feed stocks. The company was founded by Allan Otto Fog Lihme in 1992 and is headquartered in Copenhagen, Denmark.

Bioneer A/S develops and manufactures drugs. The firm's products and services drug development, molecular histology, dynamic gastric model, biomarkers and drug targets, protein manufacturing, mammalian cell technology, immune targeting, active ingredients and microorganisms. The company was founded in 2003 and is headquartered in Horsholm, Denmark.

Chempaq was formed in 2001 by Ulrik Larsen who is the founder, based on Larsen idea to redefine the hematology test by creating a single use self contained cassette module. This PAQ (cassette) was designed to be easy to use automatically calibrated and to deliver high accuracy and precision. In February 2005, the Chempaq XBC was CE marked. Later in the same year in December, the Chempaq XBC received a 510(k) clearance from the FDA. Since 2005, Doctors offices and Hospitals have provided patients with a unique infection diagnosis using the Chempaq XBC product.

Vivostat A/S provides cardiac, thoracic and orthopaedic surgery medical devices. It offers vivostat system, an automated system for the on-site preparation and application of patient-derived fibrin sealant or platelet rich fibrin. Its products include Vivostat autologous fibrin sealant for various settings in surgical areas, transfusion centers, or blood banks and Vivostat platelet rich fibrin, which utilizes the patient's own blood to derive either a surgical sealant to prevent and stop bleedings, or a gel with a high concentration of growth factors that stimulates the healing of chronic wounds, as well as provides application devices. The compnay was founded in 2001 by Tom Bjerg Lauritzen and Niels Hvid and is headquartered in Alleroed, Denmark.

Neurodan A/S develops and commercializes sensory and motor-neuro stimulation medical devices. It manufactures medical implantable devices which restore functionality to patients with central nerve damage through the application of Functional Electrical Stimulation (FES) and Neuro-Muscular Electrical Stimulation (NMES). The company was founded by Thomas Sinkjær and Morten Haugland in 1994 and is headquartered in Aalborg, Denmark.